EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial dysfunction and therapeutic perspectives in osteoporosis

Jialing Liu, Zhonghua Gao, Xiangjie Liu

Frontiers in Endocrinology · 02.02.2024 · 15

DOI: 10.3389/fendo.2024.1325317 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Endocrinology, online erschienen am 02.02.2024. Verfasst von Jialing Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Osteoporosis. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoporosis (OP) is a systemic skeletal disorder characterized by reduced bone mass and structural deterioration of bone tissue, resulting in heightened vulnerability to fractures due to increased bone fragility. This condition primarily arises from an imbalance between the processes of bone resorption and formation. Mitochondrial dysfunction has been reported to potentially constitute one of the most crucial mechanisms influencing the pathogenesis of osteoporosis. In essence, mitochondria play a crucial role in maintaining the delicate equilibrium between bone formation and resorption, thereby ensuring optimal skeletal health. Nevertheless, disruption of this delicate balance can arise as a consequence of mitochondrial dysfunction. In dysfunctional mitochondria, the mitochondrial electron transport chain (ETC) becomes uncoupled, resulting in reduced ATP synthesis and increased generation of reactive oxygen species (ROS). Reinforcement of mitochondrial dysfunction is further exacerbated by the accumulation of aberrant mitochondria. In this review, we investigated and analyzed the correlation between mitochondrial dysfunction, encompassing mitochondrial DNA (mtDNA) alterations, oxidative phosphorylation (OXPHOS) impairment, mitophagy dysregulation, defects in mitochondrial biogenesis and dynamics, as well as excessive ROS accumulation, with regards to OP ( Figure 1 ). Furthermore, we explore prospective strategies currently available for modulating mitochondria to ameliorate osteoporosis. Undoubtedly, certain therapeutic strategies still require further investigation to ensure their safety and efficacy as clinical treatments. However, from a mitochondrial perspective, the potential for establishing effective and safe therapeutic approaches for osteoporosis appears promising.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitochondrial DiseasesOsteoporosisHumansReactive Oxygen SpeciesProspective StudiesMitochondriaDNA, Mitochondrial

Stichwörter der Autor:innen

mitochondrial dysfunctionmitochondrial quality controlosteoporosisoxidative phosphorylationreactive oxygen species

Substanzen

Reactive Oxygen SpeciesDNA, Mitochondrial

Autor:innen und Institutionen

  • Department of Geriatrics, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • School of Medicine, Ezhou Vocational University, Ezhou, China.

Zitieren

APA

Liu, J., Gao, Z., & Liu, X. (2024). Mitochondrial dysfunction and therapeutic perspectives in osteoporosis. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1325317

Vancouver

Liu J, Gao Z, Liu X. Mitochondrial dysfunction and therapeutic perspectives in osteoporosis. Frontiers in Endocrinology. 2024;15. doi:10.3389/fendo.2024.1325317

BibTeX
@article{Liu2024,
  author = {Liu, Jialing and Gao, Zhonghua and Liu, Xiangjie},
  title = {Mitochondrial dysfunction and therapeutic perspectives in osteoporosis},
  journal = {Frontiers in Endocrinology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fendo.2024.1325317}
}
Kostenlos starten →